A double-blind comparison of nafarelin and leuprolide acetate for down-regulation in IVF cycles

International Journal of Fertility and Menopausal Studies

Volumn 41, Issue 5, 1996, Pages 446-449

  Corson, Stephen L ^a   Gutmann, Jacqueline N ^a   Batzer, Frances R ^a   Godai, Benjamin ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

In vitro fertilization; Leuprolide acetate; Nafarelin; Ovarian stimulation; Pituitary down regulation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LEUPRORELIN; NAFARELIN; NOSE SPRAY; PROGESTERONE; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUTEAL PHASE; OOCYTE CLEAVAGE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPOSITORY; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; DOWN-REGULATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONES; HUMANS; LEUPROLIDE; NAFARELIN; PITUITARY GLAND; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029831817     PISSN: 10693130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Meldrum DR, Wisot A, Hamilton F, et al: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 51:455, 1989.
2. Leung PCS, Lopata A, Kellow GN, et al: A histochemical study of cumulus cells for assessing the quality of preovulatory oocytes. Fertil Steril 39:853, 1983.
3. Polan ML, Anmmziata D, Russell JB, et al: Ovulation induction with human menopausal gonadotropin compared to urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa cell function. / Clin Endocrinol Metab 63:1284, 1986.
4. Insler V, Lunenfeld E, Potashnik G, et al: Ovarian stimulation concomitant with pituitary-ovarian axis GnRH agonists. Int ] Fertil 36:121, 1991.
5. Corson SL, Batzer FR, Gocial B, et al: Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis. Fertil Steril 57:601, 1992.
6. Kubik CJ, Guzick DS, Berga SL, et al: Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 54:836, 1990.
7. Poison DW, MacLachlan V, Krapez JA, et al: A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients. Fertil Steril 56:509, 1991.
8. Maroulis GB, Emery M, Verkauf BS, et al: Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization. Fertil Steiil 55:1157, 1991.
9. Ron-El R, Herman A, Golan A, et al: Gonadotropins and combined gonadotropin-releasing hormone agonists-gonadotropins protocols in a randomized prospective study. Fertil Steril 55:574, 1991.
10. Liu HC, Lai YM, Berkeley AS, et al: Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality. / Assist Reprod Genetics 9:338, 1992.
11. Homburg R, Levy T, Berkovitz D, et al: Gonadotropinreleasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59:527, 1993.
12. Chetkowski RJ, Kruse LR, Nass TE: Improved pregnancy outcome with the addition of leuproline acetate to gonadotrophins for in vitro fertilization. Fertil Steril 52:250, 1989.
13. Abdalla HI, Ahuja KK, Leonard T, et al: Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil Steril 53:473, 1990.
14. Oehninger S, Toner JP, Veeck LL, et al: Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist. Fertil Steril 57:620, 1992.
15. Penzias AS, Shamma FN, Gutmann JN, et al: Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: A randomized clinical trial. Obstet Gynecol 79:739, 1992.
16. Schmidt-Sarosi CL, Yerovi LA: The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination. Int J Fertil 39:20, 1994.
17. Martin MC, Givens CR, Schriock ED, et al: The choice of a gonadotropin-releasing hormone analog influences outcome of in vitro fertilization treatment. Am J Obstet Gynecol 170:1629, 1994.
18. Yuzpe AA, Nisker JA, Kaplan BR, et al: Nafarelin acetate for pituitary down-regulation in in vitro fertilization. Comparison of two dosages. / Reprod Med 40:83, 1995.